nitroglycerin has been researched along with scopolamine hydrobromide in 34 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 23 (67.65) | 18.7374 |
| 1990's | 3 (8.82) | 18.2507 |
| 2000's | 6 (17.65) | 29.6817 |
| 2010's | 2 (5.88) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baert, B; Beetens, J; Bodé, S; De Spiegeleer, B; Deconinck, E; Lambert, J; Slegers, G; Slodicka, M; Stoppie, P; Van Gele, M; Vander Heyden, Y | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Bell, C | 1 |
| Nimmo, WS | 1 |
| Lackner, TE | 1 |
| Hogan, DJ; Maibach, HI | 1 |
| Holdiness, MR | 1 |
| Dodson, SR; Hensley, FA; High, KM; Larach, DR; Martin, DE; Rung, GW | 1 |
| Amkraut, AA; Prevo, ME; Shaw, JE | 1 |
| Brown, L; Langer, R | 1 |
| Groth, H; Spuler, A; Vetter, W | 1 |
| Chien, YW; Moore, L | 1 |
| Jähnchen, E; Just, H; Meinertz, T | 1 |
| Haight, V; Kydonieus, AF; Matz, S; Ng, S; Shah, KR; Zeoli, L | 1 |
| Kelly, HW | 1 |
| Babar, A; Parikh, NH; Plakogiannis, FM | 1 |
| Berner, B | 1 |
| Shaw, JE | 1 |
| Odri, S; Primorac, M; Stupar, M; Vuleta, G | 1 |
| Mendeloff, AI; Salik, JO; Siegel, CI | 1 |
| Kewenter, J; Kock, NG | 1 |
| Fisher, AA | 1 |
| Macek, C | 1 |
| Worden, J | 1 |
| Burris, JF | 1 |
| Cuddy, ML; Humma, KG | 1 |
| Gever, LN | 1 |
| Bennett, BM; Dringenberg, HC; Reynolds, JN; Smith, S; Thatcher, GR | 1 |
| MATZKE, H | 1 |
| Bouin, M; Lupien, F; Poitras, P; Riberdy-Poitras, M | 1 |
| Ball, AM; Smith, KM | 1 |
| Musel, AL; Warshaw, EM | 1 |
| Benois, A; Dardare, E; Fontaine, B; Fritsch, N; Gentile, A; Tran-Van, D | 1 |
| Jenerowicz, D; Olek-Hrab, K; Polańska, A; Silny, W | 1 |
12 review(s) available for nitroglycerin and scopolamine hydrobromide
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
The promise of transdermal drug delivery.
Topics: Administration, Cutaneous; Adult; Aged; Clonidine; Female; Fentanyl; Humans; Male; Middle Aged; Nitroglycerin; Scopolamine | 1990 |
Adverse dermatologic reactions to transdermal drug delivery systems.
Topics: Administration, Cutaneous; Clonidine; Dermatitis, Contact; Estradiol; Forecasting; Humans; Nitroglycerin; Scopolamine; Time Factors | 1990 |
A review of contact dermatitis associated with transdermal therapeutic systems.
Topics: Administration, Cutaneous; Administration, Oral; Clonidine; Dermatitis, Contact; Estradiol; Humans; Hypertension; Nitroglycerin; Scopolamine; Testosterone; Time Factors | 1989 |
Transdermal delivery of drugs.
Topics: Administration, Cutaneous; Clonidine; Estradiol; Humans; Iontophoresis; Models, Theoretical; Nitroglycerin; Prodrugs; Scopolamine; Skin Absorption; Solvents | 1988 |
Transdermal drug delivery: a review of pharmaceutics, pharmacokinetics, and pharmacodynamics.
Topics: Administration, Cutaneous; Animals; Aspirin; Clonidine; Gonadal Steroid Hormones; Humans; Isosorbide Dinitrate; Nitroglycerin; Prostaglandins, Synthetic; Scopolamine; Skin; Skin Physiological Phenomena | 1988 |
[Therapeutic systems--possibilities and limits].
Topics: Administration, Cutaneous; Clonidine; Dosage Forms; Drug Administration Routes; Estradiol Congeners; Humans; Nitroglycerin; Scopolamine | 1988 |
Hercon technology for transdermal delivery of drugs.
Topics: Administration, Cutaneous; Animals; Biological Availability; Clonidine; Delayed-Action Preparations; Equipment Design; Estradiol; Humans; Isosorbide Dinitrate; Nitroglycerin; Prostaglandins; Scopolamine; Technology, Pharmaceutical | 1986 |
Postoperative pain management: can transdermal patches help?
Topics: Administration, Cutaneous; Analgesics; Anesthetics, Local; Antiemetics; Clonidine; Fentanyl; Humans; Lidocaine; Nitric Oxide Donors; Nitroglycerin; Orthopedic Procedures; Pain, Postoperative; Postoperative Nausea and Vomiting; Scopolamine | 2006 |
Cutaneous reactions to transdermal therapeutic systems.
Topics: Administration, Cutaneous; Dermatitis, Allergic Contact; Drug Delivery Systems; Drug Eruptions; Estradiol; Fentanyl; Humans; Nicotine; Nitroglycerin; Scopolamine; Testosterone | 2006 |
[Management of transdermal therapeutics in perioperative care].
Topics: Administration, Cutaneous; Analgesics; Anesthetics; Cardiovascular System; Contraindications; Diffusion; Digestive System; Drug Interactions; Estradiol; Female; Fentanyl; Humans; Hypnotics and Sedatives; Intraoperative Complications; Iontophoresis; Male; Nicotine; Nitroglycerin; Pain, Postoperative; Perioperative Care; Postoperative Complications; Postoperative Nausea and Vomiting; Scopolamine; Skin Absorption | 2009 |
Skin hypersensitivity reactions to transdermal therapeutic systems--still an important clinical problem.
Topics: Administration, Cutaneous; Dermatitis, Contact; Drug Delivery Systems; Drug Eruptions; Drug-Related Side Effects and Adverse Reactions; Estradiol; Fentanyl; Humans; Nicotine; Nitroglycerin; Scopolamine; Skin; Testosterone | 2012 |
2 trial(s) available for nitroglycerin and scopolamine hydrobromide
| Article | Year |
|---|---|
Testing of controlled-release transdermal dosage forms. Product development and clinical trials.
Topics: Administration, Cutaneous; Animals; Biological Availability; Clinical Trials as Topic; Clonidine; Delayed-Action Preparations; Drug Eruptions; Drug Evaluation; Drug Evaluation, Preclinical; Estradiol; Humans; In Vitro Techniques; Nitroglycerin; Scopolamine; Skin Absorption | 1987 |
Transdermal dosage forms.
Topics: Administration, Oral; Administration, Topical; Climacteric; Clinical Trials as Topic; Clonidine; Dosage Forms; Estradiol; Female; Humans; Kinetics; Nitroglycerin; Scopolamine; Skin Absorption | 1985 |
20 other study(ies) available for nitroglycerin and scopolamine hydrobromide
| Article | Year |
|---|---|
Transdermal penetration behaviour of drugs: CART-clustering, QSPR and selection of model compounds.
Topics: Anti-Inflammatory Agents; Cell Membrane Permeability; Cluster Analysis; Drug Evaluation, Preclinical; Humans; Models, Biological; Predictive Value of Tests; Quantitative Structure-Activity Relationship; Regression Analysis; Skin; Skin Absorption | 2007 |
Innervation and responses to vasoactive drugs of the extrinsic uterine artery of the macaque.
Topics: Acetylcholine; Anatomy, Comparative; Animals; Arteries; Autonomic Agents; Blood Pressure; Dibucaine; Female; Guanethidine; Haplorhini; Isoproterenol; Macaca; Macaca fascicularis; Nitroglycerin; Norepinephrine; Perfusion; Scopolamine; Uterus; Vasomotor System | 1976 |
Your CE topic (No. 111). Clinical application of transdermal drug delivery systems (Part II).
Topics: Administration, Cutaneous; Clonidine; Drug Therapy; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Nitroglycerin; Nursing, Practical; Scopolamine | 1990 |
The effect of a standardized premedication on oxygen saturation in the cardiac patient before transfer to the operating room.
Topics: Adult; Aged; Humans; Middle Aged; Morphine; Myocardial Revascularization; Nitroglycerin; Operating Rooms; Oximetry; Oxygen; Patients' Rooms; Preanesthetic Medication; Risk Factors; Scopolamine; Sleep; Time Factors | 1989 |
[Transdermal therapeutic systems. Possibilities and limitations].
Topics: Administration, Cutaneous; Angina Pectoris; Estradiol; Evaluation Studies as Topic; Female; Heart Failure; Humans; Nitroglycerin; Scopolamine | 1988 |
Controlled-release transdermal drug delivery.
Topics: Administration, Topical; Clonidine; Humans; Motion Sickness; Nitroglycerin; Scopolamine; Skin; Skin Absorption | 1985 |
Transdermal therapeutic systems (Part 2).
Topics: Administration, Topical; Humans; Nitroglycerin; Scopolamine; Skin Absorption | 1985 |
Pharmacokinetics of transdermal drug delivery.
Topics: Administration, Topical; Humans; Kinetics; Nitroglycerin; Pharmaceutical Preparations; Scopolamine; Skin Absorption | 1985 |
[Transdermal therapeutic systems].
Topics: Administration, Topical; Humans; Nitroglycerin; Scopolamine; Skin Absorption | 1985 |
Biliary-duodenal dynamics in man. Cineradiographic and manometric studies following administration of drugs and hormones.
Topics: Atropine; Cholecystokinin; Cineradiography; Common Bile Duct; Cyclohexanecarboxylic Acids; Duodenum; Humans; Manometry; Meperidine; Morphine; Nitroglycerin; Parasympatholytics; Scopolamine | 1973 |
The effect of some spasmolytic drugs on the choledocho-duodenal junction in man.
Topics: Atropine; Cholecystectomy; Cholelithiasis; Common Bile Duct; Humans; Morphine; Nitroglycerin; Papaverine; Pressure; Scopolamine; Time Factors | 1971 |
Dermatitis due to transdermal therapeutic systems.
Topics: Administration, Topical; Drug Eruptions; Humans; Nitroglycerin; Risk; Scopolamine | 1984 |
'Transdermal' may travel to other drugs.
Topics: Humans; Nitroglycerin; Pharmaceutical Preparations; Scopolamine; Skin | 1983 |
Transdermal delivery system--a unique drug dosage form.
Topics: Dosage Forms; Humans; Nitroglycerin; Pharmaceutical Preparations; Scopolamine | 1983 |
Potential medication error with transdermal nitroglycerin.
Topics: Administration, Topical; Aged; Angina Pectoris; Drug Labeling; Female; Humans; Medication Errors; Nitroglycerin; Scopolamine | 1984 |
Sustained drug-release patches.
Topics: Administration, Topical; Bandages; Delayed-Action Preparations; Humans; Nitroglycerin; Risk; Scopolamine | 1982 |
Pharmacist on call. Administering drugs through the skin. The new transdermal route.
Topics: Humans; Nitroglycerin; Pharmaceutical Preparations; Scopolamine; Skin | 1982 |
A novel nitrate ester reverses the cognitive impairment caused by scopolamine in the Morris water maze.
Topics: Animals; Cognition Disorders; Guanylate Cyclase; Male; Maze Learning; Muscarinic Antagonists; Nitrates; Nitroglycerin; Propane; Rats; Rats, Long-Evans; Scopolamine; Vasodilator Agents | 2000 |
[Interval treatment of angina pectoris with Nitrodurat].
Topics: Angina Pectoris; Atropine; Humans; Hypnotics and Sedatives; Menthol; Nitroglycerin; Scopolamine; Valerian | 1962 |
Tolerance to gastric distension in patients with functional dyspepsia: modulation by a cholinergic and nitrergic method.
Topics: Adult; Aged; Cholinergic Fibers; Dyspepsia; Enteric Nervous System; Female; Gastric Fundus; Humans; Male; Middle Aged; Muscarinic Antagonists; Nitric Oxide Donors; Nitroglycerin; Scopolamine; Sensory Thresholds; Somatosensory Disorders; Stress, Mechanical; Treatment Outcome | 2006 |